Amy Noffsinger
Overview
Explore the profile of Amy Noffsinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Redston M, Noffsinger A, Kim A, Akarca F, Rara M, Stapleton D, et al.
Gastroenterology
. 2021 Nov;
162(2):468-481.
PMID: 34757142
Background And Aims: Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma. A major challenge is identifying the small group with BE who will progress to advanced disease from the...
2.
Stachler M, Camarda N, Deitrick C, Kim A, Agoston A, Odze R, et al.
Gastroenterology
. 2018 Apr;
155(1):156-167.
PMID: 29608884
Background & Aims: Barrett's esophagus (BE) is the greatest risk factor for esophageal adenocarcinoma (EAC), but only a small proportion of patients with BE develop cancer. Biomarkers might be able...
3.
Glickman J, Noffsinger A, Nevin D, Ray M, Lash R, Genta R
Dig Liver Dis
. 2015 May;
47(7):549-55.
PMID: 26003395
Background: The routine use of special stains for detection of Helicobacter remains controversial. Aims: To determine the frequency of histologically atypical Helicobacter infection. Methods: All gastric biopsies received at a...
4.
Wilcox R, Perpich M, Noffsinger A, Posner M, Cooper K
Patholog Res Int
. 2011 Feb;
2011:845821.
PMID: 21331337
Hereditary diffuse gastric cancer (HDGC) is a rare, inherited cancer syndrome with at least one fourth of HDGC patients having an autosomal dominantly inherited mutation of CDH1 (E-Cadherin). Penetrance is...
5.
Roggin K, Chennat J, Oto A, Noffsinger A, Briggs A, Matthews J
Curr Probl Surg
. 2010 May;
47(6):459-510.
PMID: 20451023
No abstract available.
6.
Westerhoff M, Tretiakova M, Hovan L, Miller J, Noffsinger A, Hart J
Am J Surg Pathol
. 2010 Mar;
34(4):494-501.
PMID: 20351488
Portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE) are unusual but important causes of gastrointestinal bleeding with characteristic endoscopic appearances and critically different therapies. However, overlapping features and...
7.
Rubin B, Blanke C, Demetri G, DeMatteo R, Fletcher C, Goldblum J, et al.
Arch Pathol Lab Med
. 2010 Feb;
134(2):165-70.
PMID: 20121601
No abstract available.
8.
Pai R, Mackinnon A, Joseph L, Noffsinger A, Hart J
Am J Surg Pathol
. 2010 Feb;
34(3):355-63.
PMID: 20118768
We have recently shown that a study population of patients with at least 1 sessile serrated adenoma (SSA) are 4 times more likely to harbor synchronous serrated polyps [SSAs, traditional...
9.
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis
Pekow J, Hetzel J, Rothe J, Hanauer S, Turner J, Hart J, et al.
Inflamm Bowel Dis
. 2009 Dec;
16(8):1352-6.
PMID: 20027656
Background: The management of low-grade (LGD) and indefinite dysplasia (IND) in patients with ulcerative colitis (UC) remains controversial, as outcomes after a diagnosis of LGD or IND in previous studies...
10.
Chennat J, Konda V, Ross A, Herreros de Tejada A, Noffsinger A, Hart J, et al.
Am J Gastroenterol
. 2009 Aug;
104(11):2684-92.
PMID: 19690526
Objectives: Complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) is the endoscopic removal of all Barrett's epithelium with the curative intent of eliminating high-grade dysplasia (HGD)/intramucosal carcinoma (IMC) and reducing the...